首页> 外文期刊>International Journal of Cancer =: Journal International du Cancer >Kinesin 18A expression: clinical relevance to colorectal cancer progression.
【24h】

Kinesin 18A expression: clinical relevance to colorectal cancer progression.

机译:Kinesin 18A表达:与大肠癌进展的临床相关性。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Kif18A, a member of the kinesin superfamily of molecular motor proteins, is a microtubule depolymerase and a key regulator of chromosome congregation. Kif18A's role in cancer progression has not been well defined. Our hypothesis is that Kif18A has a role in the progression of colorectal cancer (CRC). To investigate this expression of Kif18A, mRNA was assessed by quantitative real-time PCR in 113 operative specimens of primary CRC. Kif18A was overexpressed and significantly (p < 0.0001) higher in CRC than in normal colon tissue. Kif18A overexpression in CRC significantly correlated with clinicopathologic factors such as tumor stage (p < 0.0001), lymphatic invasion (p = 0.001), lymph node metastasis (p = 0.01), venous invasion (p = 0.002) and peritoneal dissemination (p = 0.02), suggesting that it has a key role in CRC progression. In multivariate analysis, high Kif18A expression had independent significance for poorer overall survival after resection of CRC (p = 0.037). To demonstrate Kif18A's role in CRC progression, we performed translational and in situ studies. Using in vitro studies on CRC cell lines, we evaluated Kif18A's role in proliferation, migration and invasion. CRC cells transfected with Kif18A cDNA demonstrated significant enhanced migration (p < 0.01) and invasion (p = 0.018) compared to mock-transfected cells. When Kif18A was targeted with specific small interfering RNA, CRC cells had significantly reduced proliferation (p < 0.01), migration (p < 0.01) and invasion (p < 0.05). The in vitro and translational studies demonstrated that Kif18A expression is related to events of metastasis and is a significant factor for CRC progression.
机译:Kif18A是分子运动蛋白驱动蛋白超家族的成员,是微管解聚酶和染色体聚集的关键调控因子。 Kif18A在癌症进展中的作用尚未明确。我们的假设是,Kif18A在结直肠癌(CRC)的进展中起作用。为了研究Kif18A的这种表达,通过定量实时PCR对113例原发性CRC的手术标本中的mRNA进行了评估。 Kif18A在CRC中过表达并且比正常结肠组织中显着(p <0.0001)高。 CRC中Kif18A过表达与临床病理因素如肿瘤分期(p <0.0001),淋巴管浸润(p = 0.001),淋巴结转移(p = 0.01),静脉浸润(p = 0.002)和腹膜扩散(p = 0.02)显着相关),提示它在CRC的进展中起关键作用。在多变量分析中,高Kif18A表达对于CRC切除后较差的总体生存率具有独立意义(p = 0.037)。为了证明Kif18A在CRC进展中的作用,我们进行了翻译和原位研究。使用对CRC细胞系的体外研究,我们评估了Kif18A在增殖​​,迁移和侵袭中的作用。与模拟转染的细胞相比,用Kif18A cDNA转染的CRC细胞显示出显着增强的迁移(p <0.01)和侵袭(p = 0.018)。当Kif18A靶向特定的小干扰RNA时,CRC细胞的增殖(p <0.01),迁移(p <0.01)和侵袭(p <0.05)明显减少。体外和翻译研究表明,Kif18A表达与转移事件有关,并且是CRC进展的重要因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号